Skip to main content
OpenTrials
Completed

NCT Number: NCT00865150

Amino Acid and Acylcarnitine Profiles in Premature Neonates

Primary Hypotheses of the study include:

* Metabolic profiles are influenced by gestational age, chronological age, type and degree of nutritional support and illness * Metabolic profiles differ between neonates who receive commercial formula and neonates who receive primarily human breast milk * Neonates who develop parenteral associated cholestasis have metabolic markers that identify at risk patients (high serum urea nitrogen, citrulline, histidine, methionine, and succinyl carnitine and low thyroxine, serine and glutamate) * Neonates that have hypothyroidism have abnormal metabolic profiles (low tyrosine levels)

Completed

Looking for future studies?

Notify Me

Key information

Age range

23 week–31 week

Sex eligibility

All sexes

Study type

Observational

Primary location

Memorial Hospital South Bend, South Bend, Indiana, United States

Loading trial locations.

About this study

Malnutrition is a common problem in the neonatal intensive care unit. Recent studies indicate that prematurely born neonates commonly develop a severe nutritional deficit during the first weeks after birth, referred to as extrauterine growth restriction. Despite an increase in growth during the second month of hospitalization, many neonates are ultimately discharged home having grown inadequately. The early nutritional deficit affects weight gain as well as growth in length and head circumference. Aggressive administration of parenteral amino acids to improve protein accretion rates in very preterm neonates has been supported in the literature. Although tolerance of high dose amino acids has been described, researchers acknowledge that sensitive tests to monitor amino acid toxicity are not readily available in the clinical setting.

The goals of this study are:

  • To better define normal amino acid and acylcarnitine values and how they change in premature neonates
  • To measure the effect nutritional support has (human breastmilk vs. formula) on amino acid and acylcarnitines profiles
  • To measure the effect of illness (parenteral nutrition associated cholestasis) on amino acid and acylcarnitine profiles
  • To better define abnormal metabolic profiles (low tyrosine levels) in neonates that have hypothyroidism.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Documentation of informed consent
  • Inborn
  • Less than or equal to twenty four (24) hours of age
  • Gestational age between twenty three (23) weeks and 0/7 days and thirty one (31) weeks and 0/7 days as per the best estimate by the neonatologist
  • If subject is transferred to another hospital, the ability to obtain follow-up data on outcomes
  • No known major anomalies (inborn error of metabolism, chromosomal abnormalities, cyanotic congenital heart disease, gastroschisis, omphalocele, diaphragmatic hernia or other major gastrointestinal anomalies, major neurological injury or anomaly, and multiple congenital anomalies)

Exclusion criteria

  • Outborn (transferred for intensive care from another hospital)
  • Greater than twenty four (24) hours of age
  • Gestational age < 23 weeks or > 31 weeks
  • Any known major congenital anomalies

Treatment and study plan

Primary outcomes

  1. Metabolic Profile - Serum amino acid, acylcarnitine and thyroxine levels. Day of birth, (first 24 hours), Day 7, (parenteral nutrition effect), Day 28, (enteral nutrition effect), Day 42, or discharge (established enteral feeding and growth)

    Time frame: 42 Days of Life

Secondary outcomes

  1. Occurrence of any of the following: death, cholestatic liver disease, positive blood or CSF culture, NEC, IVH, or respiratory support at 36 weeks PMA.

    Time frame: 42 Days of Life

Sponsors and collaborators

Lead sponsor

Pediatrix

Other

Registry information

Official study title

How Illness and Nutritional Support Influence Amino Acid and Acylcarnitine Profiles in Premature Neonates

Important dates

Study start
2009
Primary completion
2011
Study completion
2012
First posted
Mar 19, 2009
Registry last updated
Mar 1, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.